Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe NasoVAX extension study record is available with details on its design, participants, measured immune responses, and study location.SummaryDifference33%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH terminology transition, noting that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and that both terms may appear during the transition.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the ClinicalTrials.gov study page remains inaccessible with a 403 error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now renders a 403 Forbidden error screen with basic HTML structure and site chrome, replacing the previous study-record content for the URL.SummaryDifference15%

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.